Mersana Therapeutics Inc.

NASDAQ: MRSN · Real-Time Price · USD
0.36
-0.01 (-2.44%)
At close: Jun 05, 2025, 3:59 PM
0.36
-0.25%
Pre-market: Jun 06, 2025, 08:34 AM EDT
-2.44%
Bid 0.35
Market Cap 45.48M
Revenue (ttm) 34.01M
Net Income (ttm) -74.01M
EPS (ttm) -0.59
PE Ratio (ttm) -0.62
Forward PE -0.62
Analyst Buy
Ask 0.37
Volume 1,118,445
Avg. Volume (20D) 2,857,385
Open 0.36
Previous Close 0.37
Day's Range 0.36 - 0.39
52-Week Range 0.26 - 2.83
Beta 0.82

About MRSN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRSN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
-17.24%
Mersana Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
4 months ago
-44.62%
Mersana Therapeutics shares are trading lower. The company announced initial clinical data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin.